{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:15:00Z","timestamp":1791357300760,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ejphar.2012.03.026","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T22:18:25Z","timestamp":1332541105000},"page":"226-230","source":"Crossref","is-referenced-by-count":5,"title":["Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase"],"prefix":"10.1016","volume":"683","author":[{"given":"Orit","family":"Bar-Am","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviva","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.M.","family":"Finberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2012.03.026_bb0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.bjp.0705962","article-title":"Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline","volume":"143","author":"Abassi","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/cne.902120207","article-title":"Distribution of dopamine-, noradrenaline-, adrenaline containing cell bodies in the rat medulla oblongata: demonstrated by the immunocytochemical localization of catecholamine biosynthetic enzymes","volume":"212","author":"Armstrong","year":"1982","journal-title":"Comp. Neurol."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0015","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0024-3205(88)90197-X","article-title":"In vivo voltammetry in the B3 group of serotonin neurons of the rat medulla oblongata after drug-induced modifications of arterial pressure","volume":"43","author":"Aslanian","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1353-8020(02)00053-6","article-title":"Selegiline in the treatment of Parkinson's disease: its impact on orthostatic hypotension","volume":"9","author":"Bhattacharya","year":"2003","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0025","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1532-5415.1966.tb03076.x","article-title":"Effect of antihypertensive (pargyline hydrochloride-methyclothiazide) therapy in three types of hypertension: preliminary report after one year of observation","volume":"14","author":"Campione","year":"1966","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0030","first-page":"171","article-title":"The new generation of monoamine oxidase inhibitors","volume":"38","author":"Cesura","year":"1992","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0035","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1046\/j.1471-4159.1995.64062644.x","article-title":"Participation of noradrenergic neurotransmission in the enhancement of baroreceptor reflex response by substance P at the nucleus tractus solitarii of the rat: a reverse microdialysis study","volume":"64","author":"Chan","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0040","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jnnp.63.2.228","article-title":"Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease","volume":"63","author":"Churchyard","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejphar.2012.03.026_bb0045","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0028-3908(02)00216-2","article-title":"Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours","volume":"43","author":"Finberg","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2012.03.026_bb0050","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1046\/j.1471-4159.1995.65031213.x","article-title":"Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of l-DOPA in hemiparkinsonian rats","volume":"65","author":"Finberg","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0055","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/sj.bjp.0706908","article-title":"Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and l-DOPA in the rat","volume":"149","author":"Finberg","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-2999(79)90099-2","article-title":"Central mediation of the antihypertensive effect of pargyline in spontaneously hypertensive rats","volume":"57","author":"Fuentes","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0022-3565(25)27553-X","article-title":"Effects of hydroxyamphetamine on the function of the sympathetic nervous system in normotensive subjects","volume":"155","author":"Gill","year":"1967","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jns.2011.04.011","article-title":"Autonomic dysfunction in PD: a window to early detection?","volume":"310","author":"Goldstein","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0075","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1476-5381.1975.tb06946.x","article-title":"Effects of monoamine oxidase inhibition by clorgyline, deprenyl or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration","volume":"55","author":"Green","year":"1975","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/0929867023371481","article-title":"The influence of metabolism on the MAO-B inhibitory potency of selegiline","volume":"9","author":"Haberle","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-1838(87)90023-3","article-title":"Vagal and sympathetic components of the heart rate range and gain of the baroreceptor\u2013heart rate reflex in conscious rats","volume":"21","author":"Head","year":"1987","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0090","doi-asserted-by":"crossref","first-page":"H964","DOI":"10.1152\/ajpheart.00309.2001","article-title":"Increased baroreceptor response in mice deficient in monoamine oxidase A and B","volume":"282","author":"Holschneider","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0095","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s002109900210","article-title":"Release of catecholamines in the locus coeruleus of free moving and anaesthetized normotensive and spontaneously hypertensive rats: effects of cardiovascular changes and tail pinch","volume":"361","author":"Kaehler","year":"2000","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0891-0618(96)00111-1","article-title":"Dopamine-beta-hydroxylase and tyrosine hydroxylase immunoreactive neurons in the human brainstem","volume":"10","author":"Kitahama","year":"1996","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00169238","article-title":"Release of endogenous catecholamines in the nucleus tractus solitarii during experimentally induced blood pressure changes","volume":"337","author":"Kobilansky","year":"1988","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0022-3565(25)26969-5","article-title":"False neurochemical transmitters and the mechanism of sympathetic blockade by monoamine oxidase inhibitors","volume":"147","author":"Kopin","year":"1965","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002826-200001000-00005","article-title":"Multiple-dose pharmacokinetics of selegiline and desmethylselegiline suggest saturable tissue binding","volume":"23","author":"Laine","year":"2000","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0120","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1046\/j.1471-4159.1996.67041532.x","article-title":"The effect of long term treatment with monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo","volume":"67","author":"Lamensdorf","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0125","first-page":"S1","article-title":"The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine","volume":"16","author":"Lavian","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt1971122part1245","article-title":"Physiologic, subjective and behavioural effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man","volume":"12","author":"Martin","year":"1971","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1440-1681.1985.tb02319.x","article-title":"Some cardiovascular effects of monoamine oxidase inhibitors in unanaesthetized rats","volume":"12","author":"Marwood","year":"1985","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2012.03.026_bb0140","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1097\/00002826-199417001-00009","article-title":"Safety and efficacy during long-term treatment with moclobemide","volume":"17","author":"Moll","year":"1994","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0145","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0306-4522(94)90440-5","article-title":"Baroreceptor inhibition of the locus coeruleus noradrenergic neurons","volume":"61","author":"Murase","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2012.03.026_bb0150","first-page":"213","article-title":"Antidepressive and antihypertensive effects of MAO-A inhibition: role of N-acetylserotonin. A review","volume":"7","author":"Oxenkrug","year":"1999","journal-title":"Neurobiology (Bp.)"},{"key":"10.1016\/j.ejphar.2012.03.026_bb0155","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0404.2006.00742.x","article-title":"Selegiline and blood pressure in patients with Parkinson's disease","volume":"115","author":"Pursiainen","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0160","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0165-0327(98)00226-2","article-title":"Clinical pharmacology of befloxatone: a brief review","volume":"51","author":"Rosenzweig","year":"1998","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0301-0082(95)00026-8","article-title":"Central neural organization and control of sympathetic nervous system in mammals","volume":"47","author":"Sun","year":"1995","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0170","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0006-8993(94)91023-5","article-title":"Inhibition of protein kinase C differentially affects baroreflex inhibition and hypoxic excitation of medullary vasomotor neurons in rats","volume":"636","author":"Sun","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0175","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1212\/WNL.48.3.662","article-title":"Selegiline diminishes cardiovascular autonomic responses in Parkinson's disease","volume":"48","author":"Turkka","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2012.03.026_bb0180","series-title":"Monoamine Oxidase Inhibitors: The State of the Art","first-page":"87","article-title":"Long term effects of selective MAO inhibitors on MAO activity and amine metabolism","author":"Waldmeier","year":"1981"},{"key":"10.1016\/j.ejphar.2012.03.026_bb0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01243573","article-title":"Histochemical localisation of monoamine oxidase A and B in rat brain","volume":"74","author":"Willoughby","year":"1988","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2012.03.026_bb0190","series-title":"Psychopharmacology 1; Psychopharmacology Review Series","first-page":"38","article-title":"Monoamine oxidase inhibitor antidepressants","author":"Youdim","year":"1982"},{"key":"10.1016\/j.ejphar.2012.03.026_bb0195","series-title":"Parkinson's Disease","first-page":"127","article-title":"MAO type-B inhibitors as adjunct to l-DOPA therapy","volume":"vol. 45","author":"Youdim","year":"1985"},{"key":"10.1016\/j.ejphar.2012.03.026_bb0200","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-642-46625-0_3","article-title":"Amine oxidases","author":"Youdim","year":"1988"},{"key":"10.1016\/j.ejphar.2012.03.026_bb0205","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/sj.bjp.0703826","article-title":"Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B","volume":"132","author":"Youdim","year":"2001","journal-title":"Br. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991200266X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991200266X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T22:39:20Z","timestamp":1742769560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991200266X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":41,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S001429991200266X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.03.026","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}